Your browser doesn't support javascript.
loading
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African Experience.
Glatt, Tanya Nadia; Hilton, Caroline; Nyoni, Cynthia; Swarts, Avril; Swanevelder, Ronel; Cowley, James; Mmenu, Cordelia; Moyo-Gwete, Thandeka; Moore, Penny L; Kutama, Munzhedzi; Jaza, Jabulisile; Phayane, Itumeleng; Brits, Tinus; Koekemoer, Johan; Jentsch, Ute; Nelson, Derrick; van den Berg, Karin; Vermeulen, Marion.
Afiliação
  • Glatt TN; Medical Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Hilton C; Medical Division, Western Cape Blood Service, Cape Town 7405, South Africa.
  • Nyoni C; Medical Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Swarts A; Medical Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Swanevelder R; Medical Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Cowley J; Operations Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Mmenu C; Operations Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Moyo-Gwete T; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg 2192, South Africa.
  • Moore PL; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
  • Kutama M; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg 2192, South Africa.
  • Jaza J; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
  • Phayane I; Operations Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Brits T; Operations Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Koekemoer J; Operations Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Jentsch U; Information Technology Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Nelson D; Information Technology Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • van den Berg K; Medical Division, South African National Blood Service, Roodepoort 1709, South Africa.
  • Vermeulen M; Medical Division, South African National Blood Service, Roodepoort 1709, South Africa.
Viruses ; 13(10)2021 10 12.
Article em En | MEDLINE | ID: mdl-34696480
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2021 Tipo de documento: Article